Count | |
| 6 | |
| 34 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Muscarinic Agonists/administration & dosage/*therapeutic use | 1 |
| 5 | |
| 15 | |
| 1 | |
| 1 | |
Muscarinic Antagonists/administration & dosage/*pharmacology | 1 |
| 2 | |
Muscarinic Antagonists/*chemical synthesis/chemistry/pharmacology | 1 |
| 1 | |
| 1 | |
| 7 | |
| 18 | |
| 1 | |
| 1 | |
| 8 | |
| 2 | |
| 12 | |
| 1 | |
| 1 | |
| 24 | |
| 7 | |
| 1 | |
| 2 | |
| 5 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 7 | |
| 1 | |
| 10 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 13 | |
| 49 | |
| 1 | |
| 21 | |
| 1 | |
| 1 | |
| 12 | |
| 24 | |
| 1 | |
| 1 | |
| 1 | |
| 22 | |
| 1 | |
| 8 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 16 | |
| 1 | |
| 1 | |
| 1 | |
Oligoribonucleotides/agonists/chemical synthesis/*pharmacology | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Lipopolysaccharides/*agonists/*antagonists & inhibitors/*pharmacology | 1 |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 24 | |
| 15 | |
| 1 | |
| 3 | |
| 17 | |
| 2 | |
| 3 | |
Dopamine Agonists/administration & dosage/pharmacology/*therapeutic use | 1 |
| 1 | |
Adrenergic beta-Agonists/administration & dosage/pharmacology | 1 |
| 1 | |
Cytokines/agonists/antagonists & inhibitors/metabolism/pharmacology | 1 |
Serotonin Agonists/administration & dosage/*pharmacokinetics/pharmacology | 1 |